No abstract

Porous bioactive glass-ceramics based on the 45S5 Bioglass â composition were fabricated by an acid-catalyzed sol-gel method. The effects of aging time and temperature on the structure and in vitro bioactivity were investigated. Fouriertransform infrared spectroscopy (FTIR) was carried out on the samples to understand the structure and to monitor the formation of hydroxyapatite (HA) after immersion in simulated body fluid (SBF). The bioactivity of gel-derived 45S5 glass-ceramic and amorphous 45S5 Bioglass â was compared. The results showed that an increase in both aging time and temperature can enhance crystallization, whereas bioactivity is reduced with increasing aging time but not significantly influenced by aging temperature. Compared with amorphous 45S5 Bioglass â , gelderived glass-ceramic aged for 3 d at 60°C exhibited a more rapid rate of HA formation after immersion for less than 7 d. Amorphous 45S5 Bioglass â showed higher HA formation rate after immersion in SBF for more than 7 d, whereas the quantity of formed HA on gel-derived 45S5 glass-ceramic was still comparable to that of amorphous 45S5 Bioglass â after immersion for 14 d. It is suggested that the lower bioactivity of 45S5 glass-ceramics could be outweighed by the higher surface area and higher content of Si-NBO groups in gel-derived glassceramics. The results thus confirm that gel-derived 45S5 glassceramic exhibiting bioactivity comparable to that of amorphous 45S5 Bioglass â can be fabricated by sol-gel method under suitable aging conditions. S. Bose-contributing editor Manuscript No. 34704.

A highly selective and efficient cancer therapy can be achieved using magnetically directed superparamagnetic iron oxide nanoparticles (SPIONs) bearing a sufficient amount of the therapeutic agent. In this project, SPIONs with a dextran and cisplatin-bearing hyaluronic acid coating were successfully synthesized as a novel cisplatin drug delivery system. Transmission electron microscopy images as well as X-ray diffraction analysis showed that the individual magnetite particles were around 4.5 nm in size and monocrystalline. The small crystallite sizes led to the superparamagnetic behavior of the particles, which was exemplified in their magnetization curves, acquired using superconducting quantum interference device measurements. Hyaluronic acid was bound to the initially dextran-coated SPIONs by esterification. The resulting amide bond linkage was verified using Fourier transform infrared spectroscopy. The additional polymer layer increased the vehicle size from 22 nm to 56 nm, with a hyaluronic acid to dextran to magnetite weight ratio of 51:29:20. A maximum payload of 330 μg cisplatin/mL nanoparticle suspension was achieved, thus the particle size was further increased to around 77 nm with a zeta potential of −45 mV. No signs of particle precipitation were observed over a period of at least 8 weeks. Analysis of drug-release kinetics using the dialysis tube method revealed that these were driven by inverse ligand substitution and diffusion through the polymer shell as well as enzymatic degradation of hyaluronic acid. The biological activity of the particles was investigated in a nonadherent Jurkat cell line using flow cytometry. Further, cell viability and proliferation was examined in an adherent PC-3 cell line using xCELLigence analysis. Both tests demonstrated that particles without cisplatin were biocompatible with these cells, whereas particles with the drug induced apoptosis in a dose-dependent manner, with secondary necrosis after prolonged incubation. In conclusion, combination of dextran-coated SPIONs with hyaluronic acid and cisplatin represents a promising approach for magnetic drug targeting in the treatment of cancer.

No abstract

45S5 Bioglass® (BG) scaffolds with high porosity (>90%) were coated with genipin cross-linked gelatin (GCG) and further incorporated with poly(p-xylyleneguanidine) hydrochloride (PPXG). The obtained GCG coated scaffolds maintained the high porosity and well interconnected pore structure. A 26-fold higher compressive strength was provided to 45S5 BG scaffolds by GCG coating, which slightly retarded but did not inhibit the in vitro bioactivity of 45S5 BG scaffolds in SBF. Moreover, the scaffolds were made antibacterial against both Gram-positive and Gram-negative bacteria by using polyguanidine, i.e. PPXG, in this study. Osteoblast-like cells (MG-63) were seeded onto PPXG and GCG coated scaffolds. PPXG was biocompatible with MG-63 cells at a low concentration (10 μg mL−1). MG-63 cells were shown to attach and spread on both uncoated and GCG coated scaffolds, and the mitochondrial activity measurement indicated that GCG coating had no negative influence on the cell proliferation behavior of MG-63 cells. The developed novel antibacterial bioactive 45S5 BG-based composite scaffolds with improved mechanical properties are promising candidates for bone tissue engineering